Shveta Monga

Consultant Cardiologist (Devices, CMR and ICC). DPhil @UniofOxford @RDMOxford @TheBHF alumni. Cardiac metabolism research. Clinical trials. CRT and CSP

[Shveta Monga @ShvetaMonga]

Metabolic dysfunction in Aortic Stenosis: A key piece of the pathophysiological puzzle.
So proud to share our research work on #aorticstenosis #whyCMR
@Ollie__Rider @SaulMyerson @RDMOxford @TheBHF

[CircImaging @CircImaging]

AS also causes metabolic remodeling of the myocardium. A gradient of myocardial energetic deficit & steatosis exists across the hypertrophied LV, & the metabolic changes precede irreversible LV remodeling & subclinical dysfunction @shvetamonga https://t.co/mHx8GyYviK

[Shveta Monga @ShvetaMonga]

Transforming ICC care delivery: From tertiary-centre focused to an integrated hub-and-spoke model—improving access, equity, and outcomes for patients with inherited cardiac conditions. @GWH_NHS
@OUHospitals
📍 Presenting at #BCS2025 #EmergingLeaders on 2nd June in Manchester.

[British Cardiovascular Society @BritishCardioSo]

🗳️The voting stage of our BCS Membership Elections is now open!

Ordinary, Associate (BJCA) and Affiliate members should have received an email from Civica with further details on how they cast their vote.

🗳️ Please do take the time to vote - every vote counts and all are important.

You can find out more about the BCS Membership Elections on our website > https://t.co/J9Qrd2f8cy

[Shveta Monga @ShvetaMonga]

Physiological pacing in an attempt to maintain an optimal electromechanical state.
Baseline ECG - LBBB, QRS~150ms
Beautiful LBBAP result with anodal to Ns to selective capture at low output and complete resolution of LBBB, with final paced QRS 116ms.
@GWH_NHS
#CSP #LBBAP

[Dr Rachel Clarke @doctor_oxford]

💥 Voting opens TOMORROW for elections for RCP President and Senior Roles 💥

Fellows, please vote wisely 🙏

With the abolition of NHS England, I believe @DrAsifQasim is the only candidate for President with the skills & integrity the profession needs at this troubling time. 1/3

[Shveta Monga @ShvetaMonga]

This is what makes pacing even more interesting! Beautiful LBB Po and transition captured by our brilliant physiologist @Nadiya_8 #conductionsystempacing #PROTECTHF #cathlabdiaries #betterpatientoutcomes @GWH_NHS

[Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 @DrMarthaGulati]

#WorldKindessDay
It costs us nothing to be kind, even to those who are not.
This who are not are likely the ones who need kindness the most.
#WorldKindnessDay2024

[Shveta Monga @ShvetaMonga]

The currency of leadership is social capital…what an enlightening thought process! People work for people, not for organisations.
Day 2 Emerging Leaders Programme @BritishCardioSo
#NHSleadership

[Shveta Monga @ShvetaMonga]

This is a brilliant summary! Quite an interesting and informative talk by the legend himself @NoStaticAtAll
#devicesinICC #icc2024 @AiccUk

[Shveta Monga @ShvetaMonga]

Sudden cardiac death risk assessment and indications for ICD. Changing landscape with important trials PROFID and BRITISH underway. Great talk @EylemLevelt
@AiccUk #ICCs
Listening from the comfort of my home this time…

[Will Watson @DrWillWatson]

One remarkable thing about this (clinically really useful) article is how little we know about the pathophysiology of tachycardia mediated CM. Reduced calcium transients and fibrosis seem to play a role.
https://t.co/SDQRItqsLx

[Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 @pabeda1]

Medicine is difficult! Standing over my 46 years of clinical practice, I couldn't agree more...
doi:10.1136/bmj.q2163 @Drlipid @DrMarthaGulati @PamTaubMD @biljana_parapid @AmarPut @AndrewJSauer @ErinMichos @SABOURETCardio @ctinocomesquita @OtavioBerwanger @JohnKastelein 👇🏽👇🏽

[HeartRhythm @hrs_journal]

Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group

https://t.co/iR5T6bqRLa

[Shouvik Haldar @ShouvikHaldar]

An absolute pleasure to have Professor Simon Ray, @NHSEngland National Clinical Director for #Heart Disease talking this morning about the progress in UK Cardiology over the years and where it is going!

[Will Watson @DrWillWatson]

In patients with DCM causing gene mutations, those with mild LVEF impairment were much more likely to go on to develop DCM than those with normal LVEF.
https://t.co/DM35ri76ky

[Dr Peter O'Kane @DrPeterOKane]

Fantastic today that 2 landmark RCTs our centre @UHD_NHS recruited patients for impacted ESC guidelines to direct future care:
@OctoberTrial pushing IC imaging toward 1A
@REVIVED_BCIS2 shifting PCI in ICM down to 2bB
Great CI leadership @NielsRHolm & @divaka_perera #researchwin🏆

[Amardeep Dastidar @DeepDastidar]

Access to full paper: https://t.co/iLSgMYbh16

[European Society of Cardiology @escardio]

#ESCCongressVisuals for Hotline 7:

FINEARTS-HF - #Finerenone in #HeartFailure with mildly reduced and preserved ejection fraction

MRAs in #HF - An individual patient data meta-analysis of randomised trials

FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials

#ESCCongress

[Shveta Monga @ShvetaMonga]

@BR_CMR @rdm @RDMOxford Great work, well done to both!

[Shveta Monga @ShvetaMonga]

@DeepDastidar @NEJM @escardio @ResearchNBT @VijayKunadian @NorthBristolNHS @ShaziaTHussain1 @TheBHF @ripley_david Congratulations! Great work

[Davide Capodanno @DFCapodanno]

In the RESHAPE-HF2 trial, which involved patients with moderate to severe functional mitral regurgitation who remained symptomatic despite medical therapy, transcatheter mitral-valve repair led to a lower rate of first or recurrent hospitalization for heart failure or death from cardiovascular causes during 24 months, as well as a lower rate of first or recurrent hospitalization for heart failure during 24 months, than medical therapy alone. No difference in all-cause death. #ESCCongress
https://t.co/OM8xLEmcrU